MetaCap

Integer Financial Ratios

NYSE: ITGRHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

126.61-0.04 (-0.03%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Integer ratio analysis

Integer earned a net margin of 5.5% in FY 2025, down from 7.0% a year earlier. Gross margin was 27.0% compared with a median of 27.6% over the prior 9 years. Return on equity reached 5.9%, meaning Integer generated 0.06 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.68 versus 0.61 the year before, and the current ratio was 3.32. At the end of FY 2025, ITGR traded at 26.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 14.8 to 155.0, with a median of 31.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Integer financial ratios (annual)

Integer annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)26.5739.8536.8334.4029.4134.8527.7514.7621.78155.00
Price / sales1.442.622.121.702.312.482.102.011.250.84
Price / book1.532.782.171.602.082.102.292.301.591.25
Gross margin27.0%26.7%26.3%26.0%27.6%26.6%28.2%29.8%31.2%31.4%
Operating margin11.9%12.1%10.5%8.5%11.1%11.2%12.5%12.8%11.1%8.6%
Net margin5.5%7.0%5.8%5.0%7.9%7.2%7.7%13.8%5.9%0.6%
Free cash flow margin5.7%5.8%3.9%3.1%8.5%12.5%9.3%10.1%9.0%4.4%
Return on equity (ROE)5.9%7.4%6.0%4.7%7.1%6.1%8.4%15.8%7.5%0.8%
Return on assets (ROA)3.0%3.9%3.1%2.4%3.7%3.3%4.1%7.2%2.3%0.2%
Debt / equity0.680.610.630.650.610.580.710.871.802.39
Current ratio3.322.952.802.502.842.642.322.532.542.79
Revenue growth8.0%10.3%16.9%9.0%13.8%-14.7%3.5%6.9%5.6%34.4%
EPS growth-14.0%24.9%35.2%-31.6%24.9%-20.2%-43.3%147.6%994.7%—

Related